The New York clinical-stage biopharmaceutical company has several drugs in the pipeline capable of generating hefty revenue. Developing a ketamine depression drug!
The New York clinical-stage biopharmaceutical company has several drugs in the pipeline capable of generating hefty revenue. Developing a ketamine depression drug!